Terms: = Pancreatic cancer AND CALCB, Calcitonin AND Treatment
29 results:
1. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract] [Full Text] [Related]
2. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract] [Full Text] [Related]
3. Neuroendocrine tumor with diarrhea: not always the usual suspects - a case report of metastatic calcitoninoma with literature review.
Vlaemynck K; De Man M; De Man K; Hoorens A; Geboes K
Acta Clin Belg; 2021 Jun; 76(3):239-243. PubMed ID: 31900071
[TBL] [Abstract] [Full Text] [Related]
4. Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of pancreatic Ductal Adenocarcinoma.
Saloman JL; Singhi AD; Hartman DJ; Normolle DP; Albers KM; Davis BM
Pancreas; 2018 Aug; 47(7):856-863. PubMed ID: 29975347
[TBL] [Abstract] [Full Text] [Related]
5. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor.
Valdes-Socin H; Almanza MR; Fernández-Ladreda MT; Daele DV; Polus M; Chavez M; Beckers A
Arch Endocrinol Metab; 2017; 61(5):506-509. PubMed ID: 28977163
[TBL] [Abstract] [Full Text] [Related]
6. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract] [Full Text] [Related]
7. TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
El Hage F; Durgeau A; Mami-Chouaib F
Ann N Y Acad Sci; 2013 Apr; 1283():75-80. PubMed ID: 23302073
[TBL] [Abstract] [Full Text] [Related]
8. Primary neuroendocrine carcinoma of the kidney.
Dvorackova J; Macak J; Brzula P; Tomanova R; Dokulil J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):257-60. PubMed ID: 23073523
[TBL] [Abstract] [Full Text] [Related]
9. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
[TBL] [Abstract] [Full Text] [Related]
10. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
[TBL] [Abstract] [Full Text] [Related]
11. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD
Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587
[TBL] [Abstract] [Full Text] [Related]
12. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract] [Full Text] [Related]
13. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract] [Full Text] [Related]
14. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors.
Adams S; Baum RP
Q J Nucl Med; 2000 Mar; 44(1):59-67. PubMed ID: 10932602
[TBL] [Abstract] [Full Text] [Related]
15. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.
Jensen RT
Semin Gastrointest Dis; 1999 Oct; 10(4):156-72. PubMed ID: 10548409
[TBL] [Abstract] [Full Text] [Related]
16. pancreatic endocrine tumors: recent advances.
Jensen RT
Ann Oncol; 1999; 10 Suppl 4():170-6. PubMed ID: 10436815
[TBL] [Abstract] [Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma.
Leboulleux S; Baudin E; Young J; Caillou B; Lazar V; Pellegriti G; Ducreux M; Schaison G; Schlumberger M
Eur J Endocrinol; 1999 Mar; 140(3):187-91. PubMed ID: 10216512
[TBL] [Abstract] [Full Text] [Related]
18. calcitonin-secreting tumors of the pancreas: about six cases.
Fleury A; Fléjou JF; Sauvanet A; Molas G; Vissuzaine C; Hammel P; Lévy P; Belghiti J; Bernades P; Ruszniewski P
Pancreas; 1998 May; 16(4):545-50. PubMed ID: 9598818
[TBL] [Abstract] [Full Text] [Related]
19. pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
[TBL] [Abstract] [Full Text] [Related]
20. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract] [Full Text] [Related]
[Next]
